Stocktoria

Lucid Diagnostics Inc. LUCD

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-10-14
Chart by TradingView
3/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$4.7M$4.3M$2.4M$377,000$500,000
Gross profit$377,000$500,000
Operating income-$49.6M-$46.1M-$48.5M-$56.3M-$27.4M
Net income-$58.0M-$45.5M-$52.7M-$56.2M-$28.1M
Operating cash flow-$46.5M-$44.1M-$32.8M-$29.7M-$17.7M
Free cash flow-$46.7M-$44.4M-$32.9M-$18.5M
Total assets$40.4M$30.7M$27.3M$32.5M$59.0M
Total liabilities$29.5M$25.3M$29.6M$9.5M$4.3M
Shareholders' equity$10.9M$5.4M-$2.3M$23.0M$54.7M
Ratios
Gross margin100.0%100.0%
Operating margin-1054.8%-1059.6%-1996.8%-14920.7%-5483.8%
Net margin-1232.7%-1047.6%-2169.1%-14899.5%-5615.6%
FCF margin-992.0%-1022.5%-8722.8%-3706.0%
Return on assets-143.4%-148.2%-193.1%-172.8%-47.6%
Return on equity-530.4%-844.5%2278.9%-243.7%-51.3%
Current ratio1.311.070.752.8913.45
Revenue growth8.3%79.0%544.0%-24.6%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC499,661$574,610

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001799011 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.